• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED Back to Search Results
Model Number MSZFF290
Medical Device Problem Codes Material Rupture (1546); Patient-Device Incompatibility (2682)
Health Effect - Clinical Codes Capsular Contracture (1761); Failure of Implant (1924); Swollen Lymph Nodes (2093)
Date of Event 01/07/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A review of the device history record has been completed.No deviations or non-conformances noted.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: rupture.
 
Event or Problem Description
Healthcare professional reported via regulatory agency left side rupture.Device has been explanted.
 
Event or Problem Description
Healthcare professional reported left side rupture.Device has been explanted.
 
Additional Manufacturer Narrative
Allergan did not submit this mdr within 30 days of becoming aware.Recent stimulated reporting related to 2011068-7/2/19-001-r has increased complaint and mdr volume.Allergan is implementing a plan to address the increased volumes.Device evaluation: visual analysis of the returned device identified: weight within specification, red particles in the gel, biological tissue with red color in the surface of the shell, wear abrasion, crease fold, and opening.A microscopic analysis was performed which identified sharp edge and with non-penetrating nicks assessed as surgical impact opening.A dimension measurement in the shell was performed which identified the thickness within specification.Based on the device analysis the final assessment is: a sharp edge opening with non-penetrating nicks due to surgical impact.Non-penetrating nicks.The events of capsular contracture baker grade iii and lymphadenopathy are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.
 
Event or Problem Description
Healthcare professional reported "an axillary adenopathy", "capsular contracture (baker grade iii)," and "rupture discovered by mri".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT
Common Device Name
PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS 
MDR Report Key9699807
Report Number9617229-2020-01130
Device Sequence Number3450148
Product Code FTR
UDI-Device Identifier10888628004689
UDI-Public10888628004689
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
P040046
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2012
Device Explanted Year2020
Reporter Type Manufacturer
Report Source foreign,health professional,o
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 10/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/30/2016
Device Model NumberMSZFF290
Device Catalogue NumberN-27-MF130-375
Device Lot Number2096946
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/04/2020
Initial Date Received by Manufacturer 01/14/2020
Supplement Date Received by Manufacturer01/14/2020
03/13/2020
Initial Report FDA Received Date02/12/2020
Supplement Report FDA Received Date02/12/2020
10/27/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age64 YR
-
-